| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |